ATE395101T1 - Pharmazeutische zusammensetzung, enthaltend proteine und/oder polypeptide sowie kolloidpartikel - Google Patents
Pharmazeutische zusammensetzung, enthaltend proteine und/oder polypeptide sowie kolloidpartikelInfo
- Publication number
- ATE395101T1 ATE395101T1 AT04727664T AT04727664T ATE395101T1 AT E395101 T1 ATE395101 T1 AT E395101T1 AT 04727664 T AT04727664 T AT 04727664T AT 04727664 T AT04727664 T AT 04727664T AT E395101 T1 ATE395101 T1 AT E395101T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptides
- proteins
- pharmaceutical composition
- polypeptide
- protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Dispersion Chemistry (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46270103P | 2003-04-15 | 2003-04-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE395101T1 true ATE395101T1 (de) | 2008-05-15 |
Family
ID=33299976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04727664T ATE395101T1 (de) | 2003-04-15 | 2004-04-15 | Pharmazeutische zusammensetzung, enthaltend proteine und/oder polypeptide sowie kolloidpartikel |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070167359A1 (de) |
EP (1) | EP1633440B1 (de) |
JP (1) | JP2006523683A (de) |
CN (1) | CN1774281B (de) |
AT (1) | ATE395101T1 (de) |
AU (1) | AU2004229253B2 (de) |
BR (1) | BRPI0409424B8 (de) |
CA (1) | CA2522179C (de) |
DE (1) | DE602004013769D1 (de) |
DK (1) | DK1633440T3 (de) |
ES (1) | ES2307009T3 (de) |
MX (1) | MXPA05010926A (de) |
PL (1) | PL1633440T3 (de) |
PT (1) | PT1633440E (de) |
WO (1) | WO2004091723A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2554161A1 (de) * | 2011-08-02 | 2013-02-06 | LFB Biotechnologies | Pharmazeutische Zusammensetzung enthaltend Faktor VII in Mizellen verkapselt |
GB201417589D0 (en) | 2014-10-06 | 2014-11-19 | Cantab Biopharmaceuticals Patents Ltd | Pharmaceutical Formulations |
GB201518172D0 (en) * | 2015-10-14 | 2015-11-25 | Cantab Biopharmaceuticals Patents Ltd | Colloidal particles for use in medicine |
GB201518171D0 (en) * | 2015-10-14 | 2015-11-25 | Cantab Biopharmaceuticals Patents Ltd | Colloidal particles for topical administration with therapeutic agent |
GB201518170D0 (en) * | 2015-10-14 | 2015-11-25 | Cantab Biopharmaceuticals Patents Ltd | Colloidal particles for subcutaneous administration with intravenous administration of therapeutic agent |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4348384A (en) * | 1980-10-17 | 1982-09-07 | Dainippon Pharmaceutical Co., Ltd. | Pharmaceutical composition for oral administration containing coagulation factor VIII or IX |
WO1990006952A1 (en) * | 1988-12-22 | 1990-06-28 | Kirin-Amgen, Inc. | Chemically modified granulocyte colony stimulating factor |
US5527528A (en) * | 1989-10-20 | 1996-06-18 | Sequus Pharmaceuticals, Inc. | Solid-tumor treatment method |
US5225212A (en) * | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5766897A (en) * | 1990-06-21 | 1998-06-16 | Incyte Pharmaceuticals, Inc. | Cysteine-pegylated proteins |
JPH0482839A (ja) * | 1990-07-20 | 1992-03-16 | Green Cross Corp:The | 蛋白質類・脂質小体複合体 |
NZ260909A (en) * | 1993-07-05 | 1995-04-27 | Takeda Chemical Industries Ltd | Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution |
US5874075A (en) * | 1993-10-06 | 1999-02-23 | Amgen Inc. | Stable protein: phospholipid compositions and methods |
US5705483A (en) * | 1993-12-09 | 1998-01-06 | Eli Lilly And Company | Glucagon-like insulinotropic peptides, compositions and methods |
IL112583A0 (en) * | 1994-02-08 | 1995-05-26 | Amgen Inc | Oral delivery of chemically modified proteins |
US5512549A (en) * | 1994-10-18 | 1996-04-30 | Eli Lilly And Company | Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
ATE200030T1 (de) * | 1997-01-29 | 2001-04-15 | Polymasc Pharmaceuticals Plc | Pegylationsverfahren |
JP4545928B2 (ja) * | 1998-04-27 | 2010-09-15 | ジリップ・ファーマ・ビー.ブイ. | 第viii因子及び中性リポソームを含有する薬学的組成物 |
KR20070086708A (ko) * | 1999-07-14 | 2007-08-27 | 알자 코포레이션 | 중성 지질중합체 및 그를 함유하는 리포솜 조성물 |
AU3846901A (en) * | 2000-02-18 | 2001-08-27 | Yeda Res & Dev | Oral, nasal and pulmonary dosage formualtions of copolymer 1 |
WO2002086117A1 (en) * | 2001-04-20 | 2002-10-31 | The University Of Vermont | Compositions and methods to control bleeding |
IL162319A0 (en) * | 2001-12-04 | 2005-11-20 | Univ Ben Gurion | Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
-
2004
- 2004-04-15 AU AU2004229253A patent/AU2004229253B2/en not_active Expired
- 2004-04-15 CA CA2522179A patent/CA2522179C/en not_active Expired - Fee Related
- 2004-04-15 DK DK04727664T patent/DK1633440T3/da active
- 2004-04-15 PT PT04727664T patent/PT1633440E/pt unknown
- 2004-04-15 AT AT04727664T patent/ATE395101T1/de not_active IP Right Cessation
- 2004-04-15 WO PCT/IL2004/000327 patent/WO2004091723A1/en active IP Right Grant
- 2004-04-15 MX MXPA05010926A patent/MXPA05010926A/es active IP Right Grant
- 2004-04-15 EP EP04727664A patent/EP1633440B1/de not_active Expired - Lifetime
- 2004-04-15 ES ES04727664T patent/ES2307009T3/es not_active Expired - Lifetime
- 2004-04-15 BR BRPI0409424A patent/BRPI0409424B8/pt active IP Right Grant
- 2004-04-15 CN CN2004800100998A patent/CN1774281B/zh not_active Expired - Lifetime
- 2004-04-15 US US10/553,357 patent/US20070167359A1/en not_active Abandoned
- 2004-04-15 JP JP2006507607A patent/JP2006523683A/ja active Pending
- 2004-04-15 PL PL04727664T patent/PL1633440T3/pl unknown
- 2004-04-15 DE DE602004013769T patent/DE602004013769D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK1633440T3 (da) | 2008-09-08 |
PT1633440E (pt) | 2008-08-25 |
EP1633440B1 (de) | 2008-05-14 |
AU2004229253A1 (en) | 2004-10-28 |
CA2522179A1 (en) | 2004-10-28 |
EP1633440A1 (de) | 2006-03-15 |
AU2004229253B2 (en) | 2009-11-05 |
BRPI0409424B8 (pt) | 2021-05-25 |
DE602004013769D1 (de) | 2008-06-26 |
CN1774281B (zh) | 2010-10-13 |
MXPA05010926A (es) | 2005-11-25 |
ES2307009T3 (es) | 2008-11-16 |
JP2006523683A (ja) | 2006-10-19 |
CN1774281A (zh) | 2006-05-17 |
BRPI0409424A (pt) | 2006-04-25 |
CA2522179C (en) | 2012-02-14 |
US20070167359A1 (en) | 2007-07-19 |
WO2004091723A1 (en) | 2004-10-28 |
BRPI0409424B1 (pt) | 2018-05-02 |
PL1633440T3 (pl) | 2008-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Goissis et al. | Biocompatibility studies of anionic collagen membranes with different degree of glutaraldehyde cross-linking | |
ATE397626T1 (de) | Rgd-angereicherte gelatine-ähnliche proteine mit verstärkter zellbindung | |
ATE283034T1 (de) | Pharmazeutische zusammensetzungen enthaltend faktor viii und neutrale liposomen | |
AU6819294A (en) | Oral drug delivery compositions and methods | |
ATE540973T1 (de) | Zusammensetzungen und verfahren zur verwendung von mgd-cdf zur krankheitsbehandlung | |
BR0007597A (pt) | Composição hipoalergênica contendo peptìdios tolerogênicos induzindo tolerância oral | |
HUP0400466A2 (hu) | G-CSF konjugátumok | |
ATE206308T1 (de) | Arzneizusammensetzungen enthaltend ein bakterizides permeabilität erhöhendes protein und ein tensid | |
DE69434980D1 (de) | Stabile bakterizide Proteine, welche die Permeabilität erhöhen und pharmazeutische Zusammensetzungen, diese enthaltend | |
EP2711025A3 (de) | Selbstangeordnete Peptide mit Modifikationen und Verwendungsverfahren dafür | |
ATE187740T1 (de) | Modifizierte proteine und peptide enthaltende pharmazeutische mittel | |
ATE191615T1 (de) | Aminosäurenzusammensetzungen und verwendung derselben klinischen nährung | |
CA2767026A1 (en) | Protein formulation for administering an active enamel substance | |
ATE395101T1 (de) | Pharmazeutische zusammensetzung, enthaltend proteine und/oder polypeptide sowie kolloidpartikel | |
ATE549036T1 (de) | Thymosin-alpha-1-peptid/polymer-konjugate | |
CA2071757A1 (en) | Implant compositions containing a biologically active protein, peptide or polypeptide | |
NZ591827A (en) | Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating immune reaction in a radiotherapy-induced immuno-compromised subject | |
DE60329115D1 (de) | Tumorantigenprotein und dessen verwendung | |
Paymanpour et al. | Anti-inflammatory potential of casein enzymatic hydrolysate/gelatin methacryloyl scaffolds for vital pulp therapy | |
ATE420890T1 (de) | Isoleucyl-valyl-threonyl-asparaginyl-threonyl- threonin (ivtntt) enthaltende biologisch wirksame peptide | |
WO2004032863A3 (en) | Oral formulations for proteins and polypeptides | |
ATE452139T1 (de) | Peptid-köder zur herstellung von medikamenten, die für die prävention oder behandlung von autoimmunerkrankungen bzw. problemen, die mit dem auftreten von gegen exogene proteine gerichteten antikörpern in zusammenhang stehen, bestimmt sind | |
MX9604539A (es) | Aminoacidos modificados para la distribucion de farmaco. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1633440 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |